We demonstrate the strong association with an IFNγ-STAT1-IRF1 axis and an expression hierarchy of immune checkpoints/modulators, consistent with adaptive immune resistance as a common feature operating in DLBCL. Here, IRF1 is linked to diffuse large B-cell lymphoma.